This indicates that CYCLIN E expression could correlate with the malignant potential of the cells, and thus could be considered as a marker of the aggressiveness of the disease and a new therapeutic target in pediatric BCP-ALL. This evidence concerns the gene CCNE1 and acute lymphoblastic leukemia.